Chinese companies supply many inputs for America’s military, putting the U.S. in a disturbingly vulnerable position. This threatens the survival of the small domestic manufacturers that play a critical role in America’s defense industrial base.
CPA’s chief economist Jeff Ferry joined two other panelists Wednesday to talk trade in an hour-long webinar by Industry Week magazine titled the “2024 Manufacturing Economy First Half Checkup.”
China is flooding the global market with solar panels. It’s part of an aggressive strategy by Beijing to dominate the world’s solar industry.
John Deere will lay off or offer early retirement to over 200 workers in Iowa, while at the same time the tractor producer is gearing up to move production of mid-frame skid steer loaders and compact loaders from its plant in Dubuque, Iowa to a proposed new facility in Mexico.
The U.S. solar manufacturing industry can play an important role in the 21st century economy. But that requires a smart, coherent trade and industrial strategy to counter China.
The United States is facing an unprecedented drug shortage, with a record 323 active drug shortages at the start of 2024 — the highest number since 2001.
Last week, Republicans and Democrats from the Senate’s Joint Economic Committee squared off against each other – with one side arguing in favor of industrial policy programs like the Inflation Reduction Act – and the other side arguing in favor of lower corporate taxes.
The foreign labs in China and India that make the branded drugs for CVS pharmacies nationwide are coming under increased scrutiny for unsafe manufacturing practices.
It’s time for us to stop treating China as a friend and recognize China as the enemy to our national sovereignty that it is.
Will the Pentagon spend $104 million on solar made by a Chinese company? It might be.
